Pimavanserin

Related by string. pimavanserin * * commercialize pimavanserin . pimavanserin ACADIA *

Related by context. All words. (Click for frequent words.) 75 oral prodrug 75 PDE4 inhibitor 74 Mipomersen 74 Archexin 74 Lu AA# 73 JAK inhibitor 73 Safinamide 73 cannabinor 73 Aflibercept 72 pimavanserin 72 YONDELIS 72 KRN# 72 beta 1a 72 TBC# 72 metaglidasen 72 R#/MEM # 72 IMA# 71 intranasal formulation 71 generation purine nucleoside 71 Bicifadine 71 OHR/AVR# 71 PEG SN# 71 PRT# 71 tiapamil 71 6R BH4 71 Milnacipran 71 Vicriviroc 71 targeted radiotherapeutic 71 TELINTRA 71 DDP# 71 Iloperidone 71 alvespimycin 71 mGluR2 positive 71 SinuNase TM 71 PHX# 71 Daclizumab 71 elotuzumab 71 IL# PE#QQR 71 Guanilib 71 ularitide 71 Valdoxan 71 Anavex #-# 71 Phase #b/#a clinical 71 orally inhaled migraine 71 IAP inhibitors 70 Ozarelix 70 Panzem R NCD 70 Traficet EN 70 investigational humanized monoclonal antibody 70 Tasimelteon 70 Bezielle 70 MEK inhibitors 70 Factor VIIa 70 Lixivaptan 70 MAGE A3 ASCI 70 Temsirolimus 70 midstage clinical 70 Plicera 70 GSK# [002] 70 ALN PCS 70 GW# [003] 70 Corlux 70 orally bioavailable 70 Ixabepilone 70 Androxal TM 70 phase IIb trial 70 selective modulator 70 reslizumab 70 Tyrima 70 Pazopanib 70 selective androgen receptor modulator 70 mertansine 70 PDE# inhibitors 70 Neurodex 70 Azedra 70 NNR Therapeutics 70 desvenlafaxine 70 JAK2 inhibitor 70 HCV protease inhibitors 70 PD LID 70 non nucleoside inhibitor 70 Silodosin 70 phase IIb clinical 70 HQK 70 RhuDex ® 70 Serdaxin 70 Oral NKTR 70 MKC# MT 70 otelixizumab 70 mGluR5 NAM 70 liposomal formulation 70 incyclinide 70 Pradefovir 70 ZOLINZA 70 Squalamine 70 SILENOR 70 volociximab 69 YONDELIS R 69 pan HDAC inhibitor 69 adipiplon 69 velafermin 69 Cannabinor 69 serotonin norepinephrine reuptake inhibitor 69 SYN# 69 albiglutide 69 NP2 Enkephalin 69 TG# [003] 69 mGluR2 NAM 69 regorafenib 69 Pafuramidine 69 RhuDex 69 orally administered inhibitor 69 phase IIa clinical 69 tolevamer 69 forodesine 69 Personalized Immunotherapy 69 ENMD # 69 KNS # 69 AEG# 69 CCX# 69 CYT# potent vascular disrupting 69 Synavive 69 Thiovir 69 proteasome inhibitor 69 acyclovir Lauriad R 69 Dapagliflozin 69 Xanafide 69 Onconase 69 Phase 2b Clinical Trial 69 CEQ# 69 Maribavir 69 Spiegelmer ® 69 pradefovir 69 topically administered 69 Cetrorelix 69 INS# [001] 69 ATL# [002] 69 Apoptone 69 orally dosed 69 Elagolix 69 Ambrisentan 69 5 HT2A inverse 69 RGB # 69 tezampanel 69 Meets Primary Endpoint 69 tarenflurbil 69 CB2 selective receptor agonist 69 LymphoStat B belimumab 69 polymerase inhibitor 69 Tezampanel 69 systemic RNAi therapeutic 69 Diamyd ® 69 Syncria 69 Pegloticase 69 receptor tyrosine kinase inhibitor 69 lumiliximab 69 ONCONASE R 69 histone deacetylase HDAC inhibitor 69 CDP# 69 Triolex 69 aripiprazole Abilify 69 refractory gout 69 SAR# [004] 69 AEGR 69 Zoraxel 69 Clonicel 69 Phase Ib study 69 favorable pharmacokinetic profile 69 Zybrestat 69 Avanafil 69 evaluating tivozanib 69 Xcytrin R 69 CR# vcMMAE 69 PSN# [002] 69 sodium glucose cotransporter 68 visilizumab 68 JAK inhibitors 68 novel oral anticoagulant 68 MGd 68 Zenvia ™ 68 Carfilzomib 68 Parkinson disease psychosis 68 LymphoStat B TM 68 bicifadine 68 XL# XL# 68 MKC# MKC# PP 68 Cethromycin 68 Angiocept 68 zileuton 68 S/GSK# 68 pregabalin Lyrica 68 HuMax EGFr 68 Tolvaptan 68 peripherally acting 68 GAMMAGARD 68 Vernakalant 68 PNP inhibitor 68 SNT MC# 68 multitargeted 68 BZL# 68 ospemifene 68 INCB# [001] 68 Cancidas 68 sitaxsentan 68 Cinquil 68 Pivotal Phase III 68 R roscovitine 68 Rasagiline 68 REMINYL ® 68 trial evaluating PRX# 68 tanespimycin 68 LibiGel ® 68 orBec 68 LY# [003] 68 PRX # 68 torezolid phosphate 68 Omacetaxine 68 SPRYCEL ® 68 riociguat 68 Luteinizing Hormone Releasing Hormone 68 investigational compounds 68 HuMax CD4 68 FOLOTYN ® 68 Darusentan 68 synthetic retinoid 68 HDAC Inhibitor 68 SinuNase 68 Dacogen injection 68 daclizumab 68 TLK# 68 aplindore 68 ocular formulation 68 tasimelteon 68 glucokinase activator 68 Vilazodone 68 IMiDs ® 68 Annamycin 68 Phase IIb clinical trials 68 huC# DM4 68 RezularTM 68 Alzhemed TM 68 teriflunomide 68 Talabostat 68 lucinactant 68 DU #b 68 Panzem R 68 diarrhea predominant irritable 68 lintuzumab SGN 68 OvaRex R 68 thalidomide Thalomid 68 IV Busulfex 68 deforolimus 68 Amrubicin 68 IPL# 68 highly selective inhibitor 68 AVONEX ® 68 hypoxia activated prodrug 68 Huntexil 68 Teriflunomide 68 romazarit 68 JZP 68 ATL# [001] 68 PF # [002] 68 RELOVAIR ™ 68 Ridaforolimus 68 THR beta agonist 68 CCR9 antagonist 68 VitiGam 68 ProSavin 68 trastuzumab DM1 68 MNTX 68 Reverset 68 NV1FGF 68 Nanobody 68 Aviptadil 68 baminercept 68 anti amnesic 68 urocortin 2 68 Initiate Phase 68 gefitinib Iressa 68 lomitapide 68 HuLuc# 68 PDE4 inhibitors 68 Epothilones 68 Interferon beta 1a 68 epothilone 68 canakinumab 68 Saxagliptin 67 BNC# 67 MKC# 67 cMET 67 GALNS 67 ibudilast 67 UPLYSO 67 vidofludimus 67 Anidulafungin 67 PXD# 67 CCR5 antagonist 67 pharmacological chaperone 67 Ocrelizumab 67 lurasidone 67 Phase 2a trial 67 Onalta 67 HCD# [002] 67 pharmacokinetic PK study 67 PrevOnco 67 preclinically 67 class mGluR5 inhibitor 67 Glufosfamide 67 immunomodulatory therapy 67 Symadex 67 PEGylated Fab fragment 67 agomelatine 67 Presents Preclinical Data 67 eprotirome 67 GSK# [001] 67 BIM #A# 67 dextofisopam 67 TMC# [002] 67 Aliskiren 67 mecamylamine 67 Genentech Rituxan 67 Randomized Phase 67 Nanobody ® 67 ABILIFY ® 67 Pemetrexed 67 Sudhir Agrawal D.Phil 67 Clofarabine 67 diabetic neuropathic pain 67 Arcalyst 67 Oglemilast 67 Initiates Phase II 67 Dalbavancin 67 Serdolect ® 67 Hsp# Inhibitor 67 fosbretabulin 67 virus HCV protease inhibitor 67 Azedra TM 67 IMiDs R 67 Nuvion 67 Targretin 67 selective estrogen receptor modulator 67 prokinetic agent 67 norepinephrine reuptake inhibitor 67 Drug Candidate 67 SERMs 67 rufinamide 67 Romidepsin 67 Capesaris 67 Bucindolol 67 prucalopride 67 Unit Dose Budesonide 67 pomalidomide 67 Begins Dosing 67 allosteric modulator PAM 67 ELND# 67 BRAF inhibitor 67 lixivaptan 67 dimebon latrepirdine 67 IMC #B 67 mapatumumab 67 E1 INT TM 67 GLYX 67 davalintide 67 XP# XP# 67 AGILECT R 67 dextromethorphan quinidine 67 tramiprosate 67 nitric oxide donating prostaglandin 67 ISIS # 67 Fibrillex TM 67 Laquinimod 67 Multiple Ascending Dose 67 phase III isavuconazole 67 EP #R 67 CINTREDEKIN BESUDOTOX 67 efalizumab 67 Phase IIB 67 Iluvien ® 67 IRX 2 67 methylnaltrexone 67 TLR9 agonist 67 Bosutinib 67 SAR# [002] 67 R#/MEM 67 Phase 2a Clinical Trial 67 DCCR 67 2 methoxyestradiol 67 Phase Ib clinical 67 Synavive ™ 67 Asentar 67 tubulin inhibitor 67 JAK3 inhibitor 67 rasagiline tablets 67 Voreloxin 67 PORxin TM 67 Sapacitabine 67 epothilones 67 Phase 2a clinical trials 67 indibulin 67 tezampanel NGX# 67 Vidofludimus 67 Sym# 67 bardoxolone methyl 67 Rebif ® 67 BAL# [002] 67 EVIZON TM 67 Perforomist ™ Inhalation Solution 67 GRNVAC1 67 TAFA# 67 prostone 67 Pertuzumab 67 Vidaza azacitidine 67 PSMA ADC 67 radiation sensitizer 67 renin inhibitor 67 davunetide intranasal AL 67 Rotigotine 67 Darinaparsin 67 rxRNA 67 AKT inhibitor 67 Telintra 67 paclitaxel Taxol 67 CBLC# 67 octreotide implant 67 AAG geldanamycin analog 67 DEB# 67 partial agonist 67 PEG PAL 67 XmAb# 67 Cloretazine 67 including eniluracil ADH 67 Phase 1a clinical 67 Memryte 67 Ophena TM 67 MAP# 67 CTAP# Capsules 67 RhuDex R 67 placebo controlled clinical 67 HGS# 67 BEMA Granisetron 67 LY# [002] 67 Vimpat R 67 leukotriene receptor antagonist 67 AERx iDMS 67 oxypurinol 67 pharmacodynamic properties 67 JAK Inhibitor 67 lamotrigine Lamictal 67 Tarceva TM 67 dexpramipexole 67 Kahalalide F 67 Serdaxin ® 67 DermaVir Patch 67 ONTAK 66 Bremelanotide 66 Ecallantide 66 alvimopan 66 Lacosamide 66 Glypromate 66 CINQUIL 66 Insegia 66 Octreotide 66 XL# XL# XL# XL# 66 Initiates Clinical Trial 66 2A receptor agonist 66 epigenetic therapies 66 Zolinza 66 adalimumab Humira 66 telomerase therapeutic 66 Pivotal Phase 66 VAPRISOL 66 OvaRex ® MAb 66 GLPG# 66 Zorbtive TM 66 HuMax CD# 66 Nasulin ™ 66 interferon gamma 1b 66 INCB# [003] 66 CRLX# 66 Dyloject TM 66 cangrelor 66 ALN HPN 66 Initiates Clinical 66 ORENCIA ® 66 bortezomib Velcade 66 Remicade infliximab 66 apricitabine 66 Panzem ® 66 ICA # 66 Microplasmin 66 Fulvestrant 66 Levetiracetam 66 nalbuphine ER 66 DPP4 inhibitor 66 OncoVEX GM CSF 66 atacicept 66 SinuNase ™ 66 docetaxel Taxotere ® 66 reuptake inhibitor 66 EndoTAG TM -1 66 Ropinirole 66 Epratuzumab 66 bosutinib 66 plasma kallikrein inhibitor 66 Frova ® 66 dexanabinol 66 ocrelizumab 66 Dacogen decitabine 66 Nitazoxanide 66 pioglitazone HCl 66 gamma secretase inhibitor 66 Quinamed 66 pegylated interferons 66 TRO# 66 treat chronic sinusitis 66 Catena ® 66 ATL/TV# 66 Civacir 66 non nucleoside HCV 66 vinca alkaloid 66 Fabry Disease 66 Lubiprostone 66 TKB# 66 Virulizin ® 66 Panzem 66 oral ghrelin agonist 66 Plecanatide 66 Ixempra 66 Trofex 66 Vandetanib 66 Elvitegravir 66 Ceflatonin R 66 panitumumab Vectibix 66 L BLP# 66 HCV protease inhibitor 66 Degarelix 66 neratinib 66 erlotinib Tarceva 66 oral beclomethasone dipropionate 66 5 HT3 antagonist 66 somatostatin analogue 66 Phase #b/#a trial 66 Maxy G# 66 clevidipine 66 dacetuzumab 66 HSP# inhibitor 66 Proquin XR 66 Zenvia Phase III 66 Investigational Treatment 66 TRV# [001] 66 corticosteroid dexamethasone 66 Vildagliptin 66 CRx 66 investigational monoclonal antibody 66 Aurexis 66 MOVIPREP R 66 LAF# 66 APEX PD 66 PPAR gamma agonist 66 Lupuzor 66 receptor partial agonist 66 Aplidin 66 Phase 2b Trial 66 Enzyme Replacement Therapy 66 sorafenib Nexavar 66 drug ISA# 66 Phase IIb Clinical Trial 66 Myolimus 66 rilonacept 66 ropinirole Requip 66 mTOR inhibitor 66 SomatoKine 66 Pyridorin 66 myelofibrosis polycythemia vera 66 Clolar ® 66 FM VP4 66 Enkephalin 66 ALN TTR 66 cilengitide 66 topical gel formulation 66 Irinotecan 66 selective S#P# receptor agonist 66 investigational protease inhibitor 66 OMP #R# 66 enzastaurin 66 EDEMA3 66 pseudobulbar affect PBA 66 immune modulating 66 immunoconjugate 66 Abilify aripiprazole 66 GRN# 66 subcutaneous formulation 66 Velcade bortezomib 66 brivaracetam 66 TRAIL receptor antibodies 66 opioid induced 66 ozarelix 66 ziconotide 66 alemtuzumab Campath 66 ELND-#/AZD-# 66 DOS# 66 selective kinase inhibitor 66 Lisofylline 66 vascular disrupting agent 66 MEK inhibitor 66 Allovectin 7 R 66 sodium thiosulfate STS 66 inhaled formulation 66 Solazed TM 66 Phase 2b clinical trials 66 preclinical efficacy 66 Tesmilifene 66 CCR5 mAb 66 J. Donald deBethizy 66 topiramate Topamax 66 M# rationally 66 selective adenosine 66 Fx #A 66 AVE# 66 PS# [001] 66 oral Azacitidine 66 LymphoStat B 66 AZILECT R 66 OvaRex 66 Tesetaxel 66 Davanat 66 vapreotide acetate 66 Initiates Enrollment 66 PRISTIQ 66 Gleevec imatinib mesylate 66 eniluracil 66 Aurora Kinase 66 proteasome inhibitors 66 URG# 66 palonosetron 66 LEP ETU 66 antibody MAb 66 Chrysalin 66 OMNARIS HFA 66 novel VDA molecule 66 Investigational Oral 66 dopamine partial agonist 66 cetuximab Erbitux R 66 Golimumab 66 Afatinib 66 NOX E# 66 SARMs 66 Xerecept 66 sorafenib tablets 66 Telbivudine 66 ADP receptor antagonist 66 5 HT6 receptor 66 Genz # 66 nanopharmaceutical 66 COREG CR 66 EXPAREL TM 66 Technosphere Insulin 66 anti CD3 antibody 66 acute mania 66 LEVADEX ™ 66 Ophena 66 denileukin diftitox 66 QLT# 66 GED aPC 66 sterile lidocaine patch 66 Achieves Primary Endpoint 66 Prestara 66 Topiramate 66 PEGylated interferon 66 inhaled AAT 66 Abbokinase 66 Dasatinib 66 therapeutic monoclonal antibody 66 MYDICAR ® 66 Equetro 66 novel synthetic peptide 66 Onalta ™ 66 lasofoxifene 66 Troxatyl 66 selective antagonist 66 belinostat 66 Alzheimer disease cognitive impairment 66 novel peptide 66 Onco TCS 66 NMDA receptor antagonists 66 BXT # 66 Campath ® 66 multi kinase inhibitor 66 DP VPA 66 overactive bladder AA# 66 immunotherapeutic vaccine 66 Preclinical studies suggest 65 BAY #-# 65 selective phosphodiesterase 65 Alinia 65 DAVANAT 65 beta interferons 65 CORT # 65 ILUVIEN ® 65 paroxetine sertraline 65 abacavir Ziagen 65 TOCOSOL Camptothecin 65 miconazole Lauriad ® 65 Phase IIb trials 65 cediranib 65 Enzastaurin 65 oral ridaforolimus 65 Viramidine 65 antisense drug 65 HDL Selective Delipidation 65 relapsed MM 65 Initiates Phase 2b 65 Hyphanox 65 ORENCIA R 65 oral antiviral 65 Novel Oral 65 nucleoside analog 65 Gel repository corticotropin injection 65 personalized immunotherapy 65 rALLy 65 olanzapine Zyprexa 65 Interferon alpha 65 thetreatment 65 Completes Patient Enrollment 65 MTP inhibitor 65 catheter occlusion 65 HIV integrase inhibitor 65 Lamotrigine 65 dasatinib Sprycel ® 65 dutogliptin 65 LHRH antagonist 65 novel histone deacetylase 65 oral talactoferrin 65 Phase IIa trials 65 Elotuzumab 65 Muraglitazar 65 adenosine injection 65 Prozac fluoxetine 65 HepeX B TM 65 IAP inhibitor 65 ganetespib 65 non nucleoside 65 Inhalation Solution 65 Candesartan 65 INT# [002] 65 Mesafem 65 phase IIa 65 IMC A# 65 CG# [003] 65 Peginterferon 65 Zemplar Capsules 65 Thiarabine 65 RNAi therapeutic targeting 65 Exelixis compounds 65 Adentri 65 Myocet 65 seliciclib CYC# 65 Pruvel 65 tafamidis 65 relapsed leukemia 65 immune modulatory 65 Ostabolin C TM 65 venlafaxine Effexor 65 CB1 antagonists 65 faropenem medoxomil 65 LAB CGRP 65 Menerba 65 oral rivaroxaban 65 Paxil paroxetine 65 Denufosol 65 ChronVac C R 65 E2F Decoy 65 Phase 1b trial 65 Starlix 65 PDX pralatrexate 65 neuropathic pain metabolic diseases 65 glatiramer 65 Familial Adenomatous Polyposis FAP 65 omacetaxine mepesuccinate 65 Atiprimod 65 herpetic keratitis 65 Successfully Completes Phase 65 ALGRX 65 mGluR5 antagonists 65 Androgel R 65 VA# [002] 65 etanercept Enbrel 65 Phase III Pivotal 65 EndoTAGTM 1 65 Phase #b/#a 65 Kamada AAT 65 Initiates Phase III 65 Crofelemer 65 budesonide foam 65 phase IIb 65 XL# anticancer compounds 65 anticoagulant reversing agent 65 Navelbine ® 65 Relovair 65 recurrent herpes labialis 65 Genasense ® oblimersen 65 Intervention Effectiveness 65 Dual Opioid TM 65 Liposomal 65 ruxolitinib 65 Phase IIa clinical 65 Dual Opioid 65 Cathepsin S 65 PSN# [001] 65 HP Acthar Gel repository 65 Mycophenolate Mofetil 65 dasatinib Sprycel 65 Aurora kinase inhibitor 65 delivery polymer matrix 65 compound INCB# 65 direct thrombin inhibitors 65 Naproxcinod 65 EOquin 65 Inhalation Aerosol 65 SNRI 65 dirucotide MBP# 65 PKC# 65 nucleotide analogue 65 ASG 5ME 65 aleglitazar 65 thiazolides 65 Zeldox 65 dyskinesia PD LID 65 TELINTRA R 65 Fodosine 65 TPI ASM8 65 sunitinib malate 65 PI3K/Akt pathway inhibitor 65 rivastigmine Exelon 65 rhIGF-I/rhIGFBP-3 65 MAXY VII 65 Ramoplanin 65 Multimeric 65 Tocilizumab 65 Azacitidine 65 JAK2 Inhibitor 65 sapacitabine CYC# 65 Protexia ® 65 Initiate Clinical Trial 65 Prosaptide 65 calcineurin inhibitors 65 huN# DM1 65 EDEMA3 trial 65 oncolytic virus therapies 65 citalopram Celexa 65 NXL# 65 GVAX ® 65 XYOTAX TM 65 Chemophase 65 ThGRF 65 Phenoptin 65 CCX# B 65 briakinumab 65 Proellex TM 65 NTDDS 65 iniparib 65 candidate deforolimus 65 Orapred ODT 65 Orally administered 65 Desmoteplase 65 BRIM2 65 trodusquemine 65 zanolimumab 65 Pagoclone 65 Proxinium TM 65 triphendiol 65 CANCIDAS 65 mGlu2 3 65 STEDESA 65 novel DACH platinum 65 CIMZIA ™ 65 ART# 65 Marqibo TM 65 ziprasidone Geodon 65 formerly LymphoStat B 65 candidate TNFerade biologic 65 benign prostatic hypertrophy BPH 65 A3 adenosine receptor 65 BCR ABL inhibitors 65 cancer immunotherapies 65 integrase inhibitor 65 Alexza Staccato 65 eosinophilic asthma 65 histone deacetylase inhibitor 65 Excellarate 65 NeuroSTAT ® 65 rNAPc2 65 BENICAR HCT 65 Diabetic Macular Edema 65 novel prodrug 65 oxymorphone ER 65 Trandolapril 65 oral picoplatin 65 TACI Ig 65 Romiplostim 65 labial herpes 65 inhibitor RG# 65 Nasulin TM 65 ibandronate 65 brain penetrant 65 nucleoside analogue 65 milnacipran 65 Diabetic Macular Edema DME 65 highly selective endothelin 65 vosaroxin 65 Cethrin R 65 RSD# 65 targeting PCSK9 65 JP-#/fipamezole 65 ixabepilone 65 NB S# strontium malonate 65 Sulonex 65 Abiraterone acetate 65 Icatibant 65 Tocosol Paclitaxel 65 Diamyd R 65 ZOMIG 65 AQ4N 65 PEGINTRON TM 65 Phase IIb Trial 65 Radezolid 65 entity NCE 65 radezolid 65 Presents Preclinical 65 Stedivaze 65 confirmatory Phase III 65 ALN TTR# 65 erlotinib Tarceva ® 65 Phase 2a Trial 65 Tesamorelin 65 Zemplar 65 Fc fusion protein 65 TriRima 65 Phase Ib II 65 CA4P 65 THALOMID 65 Zoloft sertraline 65 lorvotuzumab mertansine 65 PPAR gamma agonists 65 molecular imaging radiopharmaceutical 65 Patients Treated With 65 Allovectin 7 65 mGluR5 negative 65 solanezumab 65 Interferon beta 65 modulator SERM 65 CHAMPION PCI 65 Zenvia TM 65 oral nucleoside analogue 65 generation antisense 65 Benlysta belimumab 65 REG1 65 desvenlafaxine succinate 65 Teplizumab 65 CRD5 65 highly selective adenosine 65 neuroprotective properties 65 long acting muscarinic 65 Anti Tumor 65 Ceflatonin 65 corticotropin injection 65 protein kinase inhibitor 65 Zemiva TM 65 administered subcutaneously 65 JVRS 65 somatostatin analog 65 nucleotide analog 65 pertuzumab 65 Atrasentan 65 ponatinib 65 humanized monoclonal 65 CXB# 65 Curaxin 65 EOquin TM 65 CCR5 inhibitor 65 Gabapentin GR 65 ARIKACE ™ 65 AeroLEF TM 65 methylnaltrexone bromide 65 RSD# oral 65 cathepsin K inhibitor 65 Silenor ® 65 Methylnaltrexone 65 Liprotamase 65 selective orally bioavailable 65 Vaprisol 65 PRTX 65 Firazyr 65 Shigamabs ® 65 RhuDex TM 65 Cerebril TM 65 pegylated liposomal doxorubicin 65 APTIVUS r

Back to home page